undamentalytics Newsletter

Tastad Carolyn M: insider trades

Chief executive, Officer at Procter & Gamble. No open-market purchases and 39 sales not made under a pre-set plan, reported from March 3, 2014 to March 3, 2022.

What happened after Tastad Carolyn M’s sales?

After their sales, the shares moved −0.9% against the index over 12 months on average (a negative figure means selling was the right call); 56% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Tastad Carolyn M: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 39 −1.5% −2.7% 64% 9 −1.48 0.18 No reliable evidence
Sales, 12 months after the report 39 −0.9% −2.7% 56% 9 −0.43 0.68 No reliable evidence
Sales, 12 months after the trade 39 −0.9% −1.5% 54% 9 −0.41 0.70 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Procter & Gamble PG CEO - Health Care039March 3, 2014March 3, 2022

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 3, 2022March 1, 2022 PG Sale $572,592 −0.7%−2.7%−0.4%
August 19, 2021August 17, 2021 PG Sale $4,057,040 −4.3%+10.8%+8.0%
August 2, 2021August 2, 2021 PG Sale $1,101,836 −4.9%+7.8%+7.9%
May 27, 2021May 26, 2021 PG Sale $414,600 −1.3%+12.7%+11.6%
May 13, 2021May 11, 2021 PG Sale $482,230 −2.7%+16.2%+18.1%
February 26, 2021February 26, 2021 PG Sale $991,068 +1.0%+14.9%+14.6%
October 28, 2020October 27, 2020 PG Sale $7,413,869 −20.2%−34.6%−34.0%
August 20, 2020August 18, 2020 PG Sale $4,887,784 −3.7%−26.1%−24.1%
August 3, 2020July 31, 2020 PG Sale $1,224,080 +3.7%−25.9%−25.2%
February 28, 2020February 27, 2020 PG Sale $803,577 −0.7%−21.2%−18.7%
January 29, 2020January 28, 2020 PG Sale $4,720,978 +5.0%−10.7%−12.3%
August 26, 2019August 26, 2019 PG Sale $1,258,116 −9.1%−5.8%−2.3%
August 22, 2019August 20, 2019 PG Sale $1,128,995 −6.2%−1.7%−1.5%
May 23, 2019May 22, 2019 PG Sale $2,720,422 +9.5%−0.2%+1.9%
May 1, 2019May 1, 2019 PG Sale $421,283 +9.5%+14.4%+13.6%
March 4, 2019February 28, 2019 PG Sale $147,165 +5.4%+14.7%+9.6%
November 28, 2018November 28, 2018 PG Sale $1,834,765 +5.2%+19.9%+18.2%
November 21, 2018November 20, 2018 PG Sale $65,310 +2.2%+13.9%+14.5%
November 15, 2018November 15, 2018 PG Sale $580,410 +5.3%+16.8%+17.0%
November 14, 2018November 14, 2018 PG Sale $860,498 +4.1%+17.0%+14.9%
August 22, 2018August 22, 2018 PG Sale $349,197 +17.6%+45.0%+43.5%
August 3, 2018August 1, 2018 PG Sale $2,684,842 +13.8%+41.1%+42.6%
March 2, 2018February 28, 2018 PG Sale $152,716 −8.2%+23.8%+24.6%
November 13, 2017November 13, 2017 PG Sale $472,654 −13.0%+2.2%+1.5%
August 17, 2017August 15, 2017 PG Sale $158,125 −9.8%−26.4%−24.2%
March 1, 2017February 28, 2017 PG Sale $88,008 −4.9%−25.0%−28.2%
February 3, 2017February 2, 2017 PG Sale $2,659,272 −5.4%−22.7%−24.3%
November 3, 2016November 2, 2016 PG Sale $143,559 −6.2%−22.3%−22.4%
August 18, 2016August 17, 2016 PG Sale $120,216 −4.8%−3.7%−4.4%
May 31, 2016May 27, 2016 PG Sale $153,113 +3.7%−7.0%−6.5%
March 2, 2016February 29, 2016 PG Sale $97,047 −6.4%−9.2%−7.7%
February 9, 2016February 8, 2016 PG Sale $1,551,194 −10.6%−15.0%−16.2%
February 2, 2016February 1, 2016 PG Sale $472,411 −6.3%−9.9%−8.6%
May 21, 2015May 20, 2015 PG Sale $168,738 −2.7%+5.4%+5.1%
February 27, 2015February 26, 2015 PG Sale $128,557 −7.2%+3.0%+4.3%
November 6, 2014November 6, 2014 PG Sale $191,493 −5.8%−17.0%−17.7%
August 29, 2014August 29, 2014 PG Sale $1,330,711 +6.3%−11.8%−12.7%
May 5, 2014May 1, 2014 PG Sale $220,508 −4.6%−11.4%−13.5%
March 3, 2014February 27, 2014 PG Sale $158,508 −0.5%−3.4%−3.3%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Tastad Carolyn M traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.